Stock Earnings

Question 1

Quels sont les états financiers clés de Baxter International Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Baxter International Inc a un total d'actifs de $25,782, un bénéfice net loss de $-649

Question 2

Quels sont les ratios financiers clés pour BAX ?

Accepted Answer

Le ratio de liquidité de Baxter International Inc est 1.37, la marge nette est -6.1, les ventes par action sont de $20.85.

Question 3

Comment les revenus de Baxter International Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Baxter International Inc largest revenue segment is Chronic Therapies, at a revenue of 3,862,000,000 in the most earnings release.For geography, United States is the primary market for Baxter International Inc, at a revenue of 5,850,000,000.

Question 4

Baxter International Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Baxter International Inc a un bénéfice net loss de $-649

Question 5

Baxter International Inc a-t-elle des passifs ?

Accepted Answer

yes, Baxter International Inc a un passif de 18,818

Question 6

Combien d'actions en circulation Baxter International Inc a-t-elle ?

Accepted Answer

Baxter International Inc a un total d'actions en circulation de 510.92

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	11,023	10,636	10,360	15,113	12,784	11,673
Revenue Growth (YoY)	-21%	3%	-31%	18%	10%	3%
Cost of Revenue	7,161	6,590	6,180	9,690	7,626	7,038
Gross Profit	3,862	4,046	4,180	5,423	5,158	4,635
Selling, General & Admin	2,435	2,407	2,416	3,609	2,619	2,357
Research & Development	569	560	508	602	529	496
Operating Expenses	3,160	3,161	3,130	4,211	3,148	2,853
Other Non Operating Income (Expenses)	44	60	54	141	-8	2
Pretax Income	-270	-289	242	-2,353	1,477	1,292
Income Tax Expense	83	37	61	68	182	182
Net Income	-341	-649	2,656	-2,433	1,284	1,102
Net Income Growth	-416%	-124%	-209%	-289%	17%	10%
Shares Outstanding (Diluted)	514	510	508	504	508	517
Shares Change (YoY)	0%	0%	1%	-1%	-2%	0%
EPS (Diluted)	-0.66	-1.27	5.22	-4.83	2.53	2.13
EPS Growth	-413.99%	-124%	-208%	-291%	19%	11%
Free Cash Flow	244	573	1,034	532	1,479	1,159
Free Cash Flow Per Share	0.47	1.12	2.03	1.05	2.91	2.24
Gross Margin	35.03%	38.04%	40.34%	35.88%	40.34%	39.7%
Operating Margin	6.36%	8.32%	10.13%	8.01%	15.72%	15.26%
Profit Margin	-3.09%	-6.1%	25.63%	-16.09%	10.04%	9.44%
Free Cash Flow Margin	2.21%	5.38%	9.98%	3.52%	11.56%	9.92%
EBITDA	1,001	1,882	2,313	2,615	2,900	2,605
EBITDA Margin	9.08%	17.69%	22.32%	17.3%	22.68%	22.31%
D&A For EBITDA	299	997	1,263	1,403	890	823
EBIT	702	885	1,050	1,212	2,010	1,782
EBIT Margin	6.36%	8.32%	10.13%	8.01%	15.72%	15.26%
Effective Tax Rate	-30.74%	-12.8%	25.2%	-2.88%	12.32%	14.08%

Baxter International Inc (BAX) Price

BAX Stock Price Chart

BAX Income

Follow-Up Questions